혈액 가온기 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측 : 제품별, 용도별, 최종사용자별, 지역별＆경쟁(2021-2031년)

The Global Blood Warmer Market is projected to expand from a valuation of USD 1.71 Billion in 2025 to USD 2.36 Billion by 2031, advancing at a CAGR of 5.52%. These specialized medical devices are essential for heating intravenous fluids and blood products to body temperature before transfusion, thereby significantly reducing the risk of hypothermia during major surgeries or trauma care. This market growth is fundamentally underpinned by the rising volume of complex surgical procedures and the increasing prevalence of chronic conditions requiring massive transfusions, alongside strict clinical protocols that mandate precise patient temperature management to enhance post-operative recovery rates.

According to the American Cancer Society, the number of new cancer diagnoses in the United States surpassed 2 million for the first time in 2024, a statistic that highlights the escalating need for surgical interventions and supportive technologies such as blood warming systems. However, the market faces a substantial challenge regarding the high acquisition and operational costs linked to advanced warming units and their proprietary disposables. These financial constraints can deter adoption in smaller healthcare facilities or developing regions where budget allocations for auxiliary surgical devices are limited, potentially restricting broader market penetration despite the evident clinical benefits.

Market Driver

The rising incidence of trauma and emergency cases serves as a primary driver for the adoption of blood warming systems, particularly within prehospital and emergency room environments. Severe injuries often necessitate massive transfusion protocols where the rapid administration of cold fluids can trigger the trauma triad of death-comprising hypothermia, coagulopathy, and acidosis-prompting emergency services and trauma centers to integrate high-flow warming devices to stabilize patient core temperatures during critical resuscitation. As reported by the National Highway Traffic Safety Administration in April 2024, an estimated 40,990 individuals died in motor vehicle traffic crashes in the United States in 2023, a figure that underscores the significant burden of vehicular trauma requiring immediate and complex medical intervention involving fluid resuscitation.

Simultaneously, increasing demand from the military and defense sectors is accelerating the development and procurement of portable, ruggedized blood warming solutions tailored for austere environments. Defense organizations are prioritizing advancements in field medical care to improve survival rates for combat casualties suffering from hemorrhagic shock, creating a need for lightweight, battery-operated equipment. This strategic focus is supported by substantial financial commitments; according to the Stockholm International Peace Research Institute's April 2024 report, global military spending rose by 6.8 percent to reach a historic high of $2443 billion in 2023, facilitating increased procurement of field medical gear. This military initiative complements the broader civilian need for blood products, as the American Red Cross noted in 2024 that someone in the United States requires blood or platelets every two seconds, highlighting the universal necessity for effective temperature management during frequent transfusions.

Market Challenge

The significant acquisition and operational costs associated with advanced blood warming units and their proprietary disposables act as a major barrier to the broader expansion of the Global Blood Warmer Market. Although the clinical benefits are well-established, the financial burden of procuring these devices creates hesitation among procurement departments, particularly in smaller community hospitals and developing regions where capital is limited. The requirement for specialized, single-use disposable sets for each transfusion exacerbates this issue by converting a one-time capital expense into a perpetual operational cost, compelling many healthcare facilities to defer upgrading to newer, more efficient warming technologies in favor of retaining legacy systems to preserve short-term cash flow.

This economic pressure directly inhibits market growth by restricting the addressable market to only the most well-funded institutions. When hospitals face shrinking operating margins, budget allocations for auxiliary surgical support devices are often the first to be reduced. According to the American Hospital Association, total hospital expenses increased by 5.1% in 2024, a rate that significantly outpaced overall inflation and placed immense strain on facility budgets. This escalating cost environment limits the fiscal flexibility required to invest in specialized technologies like blood warmers, thereby stalling market penetration and reducing the overall volume of unit sales despite the rising volume of surgical procedures.

Market Trends

The integration of Smart Connectivity and IoT Capabilities is reshaping the market as healthcare providers prioritize devices that offer seamless data interoperability and automated record-keeping. Modern blood warming systems are increasingly equipped with wireless modules that allow for the real-time transmission of temperature data directly to electronic health records (EHR), ensuring strict compliance with clinical documentation standards. This digitization reduces administrative burdens on nursing staff and enhances patient safety by enabling continuous remote monitoring of infusion parameters, a trend underscored by ECRI in December 2024, which identified the deployment of AI-enabled health technologies as the top safety focus for 2025, reflecting the critical volume of smart, connected devices entering the clinical environment.

Concurrently, the market is experiencing a decisive shift toward single-use disposable warming sets, driven by the imperative to eliminate cross-contamination and streamline hospital workflows. Healthcare facilities are favoring dry-heat technologies that utilize sterile, patient-specific cassettes and tubing, thereby negating the need for time-consuming sterilization procedures between cases. This preference for high-turnover consumables promotes operational efficiency in high-throughput surgical centers while adhering to rigorous infection prevention protocols. This demand for consumable-driven medical solutions is fueling financial growth for key manufacturers; for instance, Solventum reported a 3.9% increase in total sales in August 2025, with its MedSurg segment cited as a primary contributor to this growth driven by robust demand for surgical supplies.

Key Market Players

• Stryker Corporation
• Gentherm Medical, LLC
• Belmont Instrument, LLC
• 3M Company
• ICU Medical, Inc.
• Vyaire Medical, Inc.
• The Surgical Company Holding B.V.
• Life Warmer Inc.
• Estill Medical Technologies, Inc.
• Smisson-Cartledge Biomedical, LLC

Report Scope

In this report, the Global Blood Warmer Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blood Warmer Market, By Product

• Portable Blood/IV Warmers Device
• Non-portable Blood/IV Warmers

Blood Warmer Market, By Application

• Surgery
• Acute Care
• New Born Care
• Homecare
• Others

Blood Warmer Market, By End User

• Hospitals/Clinic
• Ambulatory Services
• Defense Forces
• Rescue Forces

Blood Warmer Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Blood Warmer Market.

Available Customizations:

Global Blood Warmer Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Blood Warmer Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Portable Blood/IV Warmers Device, Non-portable Blood/IV Warmers)
  • 5.2.2. By Application (Surgery, Acute Care, New Born Care, Homecare, Others)
  • 5.2.3. By End User (Hospitals/Clinic, Ambulatory Services, Defense Forces, Rescue Forces)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Blood Warmer Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Blood Warmer Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Blood Warmer Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Blood Warmer Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Blood Warmer Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Blood Warmer Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. France Blood Warmer Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Blood Warmer Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Blood Warmer Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Blood Warmer Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia Pacific Blood Warmer Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Blood Warmer Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Blood Warmer Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Blood Warmer Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Blood Warmer Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Blood Warmer Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. Middle East & Africa Blood Warmer Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Blood Warmer Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Blood Warmer Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Blood Warmer Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. South America Blood Warmer Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Blood Warmer Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Blood Warmer Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Blood Warmer Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Blood Warmer Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Stryker Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Gentherm Medical, LLC
• 15.3. Belmont Instrument, LLC
• 15.4. 3M Company
• 15.5. ICU Medical, Inc.
• 15.6. Vyaire Medical, Inc.
• 15.7. The Surgical Company Holding B.V.
• 15.8. Life Warmer Inc.
• 15.9. Estill Medical Technologies, Inc.
• 15.10. Smisson-Cartledge Biomedical, LLC

16. Strategic Recommendations

17. About Us & Disclaimer